Abstract:
A lithium secondary battery includes: a lithium secondary cell including a surface parallel to an electrode surface, a single-body pressing structure configured to apply pressure to the surface of the lithium secondary cell, wherein the pressing structure is configured to contract and expand in response to a change of volume of the lithium secondary cell; and a housing that accommodates the lithium secondary cell and the pressing structure, wherein an area of a surface of the lithium secondary battery which is parallel to the electrode surface is less than an area of a surface of the lithium secondary battery which is orthogonal to the electrode surface.
Abstract:
An organometallic compound represented by Formula 1: wherein in Formula 1, groups and variables are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2, Formula 1 wherein M is selected from iridium (Ir), platinum (Pt), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), thulium (Tm), and rhodium (Rd), and wherein L1 is a ligand represented by Formula 2A and L2 is a ligand represented by Formula 2B, and wherein L1 and L2 in Formula 1 are different from each other,
Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, R37 is hydrogen, deuterium, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; and ring CY1, R21 to R26, R30a, and R30b, are as described herein.
Abstract:
Provided is an organometallic compound represented by Formula 1, an organic light-emitting device including the same, and an electronic apparatus including the organic light-emitting device.
Ir(L1)(L2)(L3) Formula 1
L1 to L3 in Formula 1 are the same as described in the present specification.
Abstract:
An organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound:
wherein, in Formula 1, Y2, a ring CY2, R1 to R8, R20, A1 to A7 and d2 may be each independently the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: M1(Ln1)n1(Ln2)n2 Formula 1 wherein, in Formula 1, Ln1 is a ligand represented by Formula 1A, Ln2 is a ligand represented by Formula 1B, n1 is 1 or 2, and n2 is 1 or 2: wherein CY1 is a 6-membered N-containing heterocyclic group, a 6-membered N-containing heterocyclic group condensed with a C1-C30 carbocyclic group, or a 6-membered N-containing heterocyclic group condensed with a C5-C30 heterocyclic group, CY21 is a 5-membered carbocyclic group or a 5-membered heterocyclic group, X31 and X32 are each independently O or S, * and *′ each indicate a binding site to M1, and R10, R20 to R22, R31 to R37, b10, and b20 are as provided herein.
Abstract:
An organometallic compound, represented by Formula 1: M1(Ln1)n1(Ln2)n2 Formula 1 wherein, Ln1 is a ligand represented by Formula 1-1, Ln2 is a ligand represented by Formula 2-1 or Formula 2-2, n1 may be 1 or 2, and n2 may be 1 or 2, wherein the other substituents may be understood by referring to the descriptions thereof provided herein:
Abstract:
A positive electrode includes a composite material including a positive active material and a coating layer on a surface of the positive active material, wherein the coating layer includes a copolymer including a first repeating unit represented by Formula 1 below and a second repeating unit represented by Formula 2 below: wherein Ar1, R1 to R6, A, A1, Y−, m, and n are the same as defined in the specification.